How effective is Humira for Ankylosing Spondylitis? (a real world drug study)

Summary:

Overall ratings: 3.2/5
Long term ratings: 3.6/5

This is a phase IV clinical study of how effective Humira (adalimumab) is for Ankylosing spondylitis and for what kind of people. The study is created by eHealthMe from 213 Humira users and is updated continuously.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 743 drugs and 1,050 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.


On Aug, 11, 2026

213 people are studied for taking Humira in Ankylosing spondylitis

Overall effectiveness (number of people):

Does Humira work for your Ankylosing spondylitis (overall)?

Long term (1+ years) effectiveness (number of people):

Does Humira work for your Ankylosing spondylitis (long term)?

Humira effectiveness for Ankylosing spondylitis (number of people):

Overall:
  • not at all: 14
  • somewhat: 41
  • moderate: 64
  • high: 70
  • very high: 24
Long Term:
  • not at all: 3
  • somewhat: 11
  • moderate: 28
  • high: 44
  • very high: 18

Gender of people who take Humira for Ankylosing spondylitis *:

  • female: 55.87 %
  • male: 44.13 %

Age of people who take Humira for Ankylosing spondylitis *:

  • 0-1: 0.9400000000000001 %
  • 2-9: 0.0 %
  • 10-19: 3.29 %
  • 20-29: 9.86 %
  • 30-39: 23.47 %
  • 40-49: 30.05 %
  • 50-59: 24.88 %
  • 60+: 7.51 %

Who find Humira more effective for Ankylosing Spondylitis?

Gender of people who take Humira for Ankylosing spondylitis *:

  • female: 45.74 %
  • male: 54.26 %

Age of people who take Humira for Ankylosing spondylitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.26 %
  • 20-29: 11.7 %
  • 30-39: 19.15 %
  • 40-49: 34.04 %
  • 50-59: 23.4 %
  • 60+: 7.45 %

* Approximation only. Some reports may have incomplete information.

Do you take Humira?

- You can start a phase IV clinical trial to monitor Humira safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: